Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQ84CE
|
|||
| Drug Name |
AMG 592
|
|||
| Synonyms |
efavaleukin alpha
Click to Show/Hide
|
|||
| Drug Type |
Fusion protein
|
|||
| Indication | Graft-versus-host disease [ICD-11: 4B24; ICD-9: 279.5] | Phase 1/2 | [1] | |
| Company |
Amgen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03422627) A Phase 1b/2 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Efavaleukin Alfa in Adult Subjects With Steroid Refractory Chronic Graft Versus Host Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.